Tim Anderson

4 Reasons To Buy, 2 Controversies Surrounding AstraZeneca

Which Pharma Players Dominate The Lung Cancer Space?

Dow 20K - It's All In Your Mind

Which Pharma Players Dominate The Lung Cancer Space?

Dow 20K - It's All In Your Mind

What If Trump Keeps Badmouthing Drug Pricing?

Bernstein Says Merck's Lung Cancer Drug Will Lead The Market Near-Term, But Long-Term Market Share Harder To Predict

What If Trump Keeps Badmouthing Drug Pricing?

Bernstein Says Merck's Lung Cancer Drug Will Lead The Market Near-Term, But Long-Term Market Share Harder To Predict

Goldman: High Yield Selloff Won't Stabilize Until Oil Does

Tim Anderson Recent News

Floor Trader: Why Goldman Is Wrong (Again) On $20 Oil Prediction

Why Netflix And Google Are No House Of Cards

Anderson On Apple: Watch Volume Closely, It Was 70% Higher Than Average On Thursday

Tim Anderson On Greece: 'This is A Very Fluid Situation...Don't Be Surprised To See Conflicting Headlines' Throughout The Morning

Anderson: 'A Greece Induced Rally? Really??'

Expert Roundtable: Is The Fed Just 'Kicking The Can Down The Road'?

Everything You Need To Know Before Today's Fed Announcement

Tim Anderson: 'Virtually No One' Expects The Fed To Announce A Rate Hike Today

3 Experts Weigh In Before Retail Sales Report

#PreMarket Prep For The Week Of June 8: No Summer Break From Markets With These NYSE Traders, Fund Mangers & Market Technicians

Friday's Jobs Report: What Experts Are Saying Ahead Of The Release

Market Vet Weighs In On Apple Into Earnings

If You Want To Be Bullish, Check Out Transportation, Says Pro Tim Anderson

Why GoDaddy Is The 'Anti-Twitter'

Did Apple Just Time The Bond Market Nearly Perfect (Again)?

#PreMarket Prep For The Week Of February 2: Trading Ideas For Equities, Bonds & Currencies

Why This NYSE Floor Trader Is Warning Against Transocean

#PreMarket Prep Guest List For The Week Of January 12, 2015

Unusual Drop In Intel Due To Problems With Regulation NMS

UPDATE: Bernstein Downgrades Merck & Co. on Negative Outlook